Electrically Guided Bachmann's Bundle Pacing: A Lead Placement Strategy With Potential Antiarrhythmic Benefits
Launched by UNIVERSITY OF VERMONT · Nov 27, 2021
Trial Information
Current as of June 02, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject is \>18 years old
- • Subject is referred for permanent pacemaker implantation with an indication for an atrial lead
- • Subject has either paroxysmal atrial fibrillation or baseline intra-atrial conduction delay (P-wave duration \>120ms on a 12-lead ECG)
- • Subject is expected to remain available for standard-of-care pacemaker follow-up visits and study questionnaires
- Exclusion Criteria:
- • Subject has permanent atrial fibrillation or is in atrial fibrillation in the pre-operative area prior to the procedure (inability to assess paced P-wave morphology)
- • Subject has pacemaker implantation prior to planned atrioventricular nodal ablation
- • Subject has resting spontaneous sinus rate \>85 beats-per-minute
- • Subject has left ventricular ejection fraction \<45%
- • Subject is unable or unwilling to complete baseline or follow up quality of life questionnaires
- • Subject is currently enrolled in a potentially confounding trial
- • Subject is pregnant
- • Subject's anticipated life expectancy is less than 1 year
About University Of Vermont
The University of Vermont (UVM) is a leading academic institution known for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UVM leverages its diverse expertise in medicine, public health, and biomedical sciences to conduct cutting-edge clinical studies. The university aims to translate scientific findings into effective treatments and interventions, ultimately improving patient outcomes and contributing to the broader medical community. UVM's research facilities and access to a wide patient population support its mission to foster a culture of inquiry and excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Burlington, Vermont, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials